| Today, Tue, Dec 29, 2009 | | | 5-Star Stocks Poised to Pop: Repligen at Motley Fool (Tue 1:45pm)
| | Tue, Dec 15, 2009 | | | Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program PR Newswire (Tue, Dec 15)
| | Mon, Dec 14, 2009 | | | Biotech's Latest Failed Trials, Missed Targets at Seeking Alpha (Mon, Dec 14)
| | Wed, Dec 9, 2009 | | | Movado Group, Repligen: Biggest Price Decliners (MOV, RGEN) at The Wall Street Journal Online (Wed, Dec 9)
| | | Repligen says imaging agent misses main study goal AP (Wed, Dec 9)
| | | UPDATE - Repligen pancreatic imaging agent does not meet goal at Reuters (Wed, Dec 9)
| | | Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging PR Newswire (Wed, Dec 9)
| | Tue, Dec 8, 2009 | | | Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas PR Newswire (Tue, Dec 8)
| | Wed, Nov 11, 2009 | | | REPLIGEN CORP Financials EDGAR Online Financials (Wed, Nov 11)
| | Sun, Nov 8, 2009 | | | New Star Analyst Rankings for Repligen Corporation StarMine (Sun, Nov 8)
| | Thu, Nov 5, 2009 | | | Repligen Corp. F2Q09 (Qtr. End 09/30/09) Earnings Call Transcript at Seeking Alpha (Thu, Nov 5)
| | | Repligen Q2 Fiscal Year 2010 Earnings Call scheduled for 10:00 am ET today CCBN (Thu, Nov 5)
| | | REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online (Thu, Nov 5)
| | | Repligen Q2 Fiscal Year 2010 Earnings Release - Before Market Open CCBN (Thu, Nov 5)
| | | Repligen Reports Second Quarter Fiscal Year 2010 Financial Results PR Newswire (Thu, Nov 5)
| | Tue, Nov 3, 2009 | | | Repligen to Present at the Merriman Curhan Ford 6th Annual Investor Summit Tuesday, November 10th, 1:40 p.m. EST PR Newswire (Tue, Nov 3)
| | Thu, Oct 29, 2009 | | | Repligen Announces Conference Call of Second Quarter Fiscal Year 2010 Results PR Newswire (Thu, Oct 29)
| | Fri, Oct 23, 2009 | | | Repligen Licenses Potential Treatment for Spinal Muscular Atrophy Call scheduled for 8:30 am ET today CCBN (Fri, Oct 23)
| | Thu, Oct 22, 2009 | | | Repligen Licenses Potential Treatment for Spinal Muscular Atrophy PR Newswire (Thu, Oct 22)
| | Mon, Oct 19, 2009 | | | Repligen Announces Completion of Patient Treatment in Phase 3 Clinical Trial of RG1068 in MRI Imaging of the Pancreas PR Newswire (Mon, Oct 19)
| Add RGEN News to My Yahoo!:

| |
|